1. DOUBLE‐EXPRESSOR LYMPHOMAS DO NOT HAVE INFERIOR OUTCOME AFTER AUTOLOGOUS STEM‐CELL TRANSPLANT IN THE FIRST LINE TREATMENT. (June 2017) Authors: Trneny, M.; Campr, V.; Pytlik, R.; Klener, P.; Stritesky, J.; Jaksa, R.; Boudova, L.; Benesova, K.; Koren, J.; Trnkova, M.; Blahovcova, P.; Klanova, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. RITUXIMAB MAINTENANCE AFTER NORDIC PROTOCOL (R‐MAXICHOP/HD‐ARAC/ASCT) SIGNIFICANTLY PROLONGS SURVIVAL IN YOUNG MANTLE CELL LYMPHOMA PATIENTS. (June 2017) Authors: Klener, P.; Salek, D.; Mocikova, H.; Blahovcova, P.; Pytlik, R.; Janikova, A.; Prochazka, V.; Campr, V.; Boudova, L.; Jaksa, R.; Kodet, R.; Trneny, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. R‐CHOP/R‐HDAC AND RITUXIMAB MAINTENANCE RESULTS IN HIGH COMPLETE REMISSION RATE, MINIMAL RESIDUAL DISEASE NEGATIVITY, AND EXCELLENT SURVIVAL IN ELDERLY MCL PATIENTS. (June 2017) Authors: Klener, P.; Fronkova, E.; Belada, D.; Forsterova, K.; Pytlik, R.; Kalinova, M.; Simkovic, M.; Salek, D.; Mocikova, H.; Prochazka, V.; Blahovcová, P.; Janikova, A.; Markova, J.; Obr, A.; Berkova, A.; Vaskova, M.; Mejstrikova, E.; Campr, V.; Kubinyi, J.; Jaksa, R. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗